SCR-LIP-000338 · Claim · machine-readable JSON →

This review proposes that lipedema patients (including those with BMI <30 kg/m²) can develop subclinical and clinical bilateral systemic lymphedema in the lower limbs, which worsens and progresses to the trunk and upper limbs as obesity develops, and contributes to increased limb volume requiring exclusion before liposuction.

Claim at a glance

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Hypotheses and Evolution in the Current Treatment of Lipedema Syndrome — Pereira de Godoy & Guerreiro Godoy (2022) ✓ verified — consistent · review · 2022 · reading confidence: moderate
“Pacientes com lipedema e BMI <30 kg/m² podem desenvolver linfedema sistêmico subclínico e clínico bilateral em MMII (de Godoy 2019, 2020) À medida que paciente se torna obesa, há aumento significativo de linfedema sistêmico subclínico/clínico em MMII, progredindo para tronco e MMSS”
Narrative review/hypothesis article asserting that lipedema can be accompanied by progressive subclinical-to-clinical systemic lymphedema and increased limb volume; supports the affirmative direction but is opinion/hypothesis-driven with no

Populationlipedema patients, including BMI <30 kg/m²

Conditionlipedema

Exposuredevelopment of obesity and bilateral systemic lymphedema

Comparatorsubclinical vs clinical lymphedema stages

Outcomelimb volume increase and lymphedema progression

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.